Pipeline

Debiopharm’s projects cover all molecule type proteins, peptides, small molecules

Oncology

Infectious disease

Program Indication Mode of Action
Discovery Preclinical Phase I Phase II Phase III
_ Debio 1561
Infectious diseases – Sample prep. Technology
Sample prep. Technology
_ Debio 1453
N. gonorrhoeae – Fabl inhibitor
Fabl inhibitor
CARB-X
_ Debio 1454/S
A. baumannii – Fabl inhibitor
Fabl inhibitor
CARB-X
_ Debio 1454/M
GI disorders – microbiome remodeling
microbiome remodeling
Takeda
ODD: Orphan Drug Designation
FT: Fast-Track
QIDP: Qualified Infectious Disease Product
CARB-X: CARB-X
Takeda: Takeda

Our commercialized products

  • Triptorelin

    Triptorelin is a gonadotropin releasing hormone (GnRH) agonist

    Discover
  • Oxaliplatin

    A major advance in the history of cancer treatment

    Discover

Clinical trials

Debiopharm’s vision of healthcare is not limited to making new medicines available. We strongly believe you can be an actor in your own medical care.

More about clinical trials